Expression of interleukin (IL)-5 and IL-9 receptors on neutrophils of horses with heaves.

This research explores the role of certain immune-system proteins on white blood cells in horses suffering from heaves, an allergic respiratory disease. The findings suggest that these proteins could potentially activate the white blood cells to contribute to pro-inflammatory responses.

Research Background and Objective

• The focus of this study was an illness in horses known as heaves, which is a kind of respiratory disease related to allergies triggered by dust particles in the environment.
• Neutrophils, a type of white blood cell, are heavily involved in cases of heaves, but little is known about how they contribute to the allergic response.
• The goal was to investigate the presence of receptors for the Th2-type cytokines, interleukin (IL)-5 and IL-9, on the neutrophils of horses suffering from heaves. Cytokines are proteins that perform a critical role in cell signalling in the immune system. Thus, looking at the presence of their receptors on neutrophils may provide significant insights into immune response.

Research Approach and Findings

• Pulling from a pool of 12 horses, seven had heaves while five were healthy controls. The research team isolated neutrophils from the horses before and after three weeks of continuous natural allergen exposure (through stabling).
• The significant finding was that horses with heaves showed a notably higher number of neutrophils expressing IL-5 and IL-9 receptors while in a pasture environment, which further increased during stabling.
• Interestingly, the control group of horses without heaves showed no such increase of expression, providing a contrast which further strengthens the assertion of the research.

Conclusions and Implications

• The study provides a potential explanation for how Th2-type cytokines might activate neutrophils in horses with heaves.
• Understanding this mechanism could have notable implications both for diagnosing the disease and developing targeted treatments. The activation of these receptors could potentially serve as a diagnostic marker for heaves, and therapy could focus on controlling the expression of IL-5 and IL-9 receptors to potentially limit or manage the disease.